Viagra significantly more effective than Uprima in the treatment of erectile dysfunction!
Viagra (sildenafil citrate) demonstrated superior efficacy to Uprima (apomorphine hydrochloride) in the treatment of men with erectile dysfunction (ED), according to an open-label study presented at the XVIIIth Congress of the European Association of Urology (EAU) 12 - 15 March 2003.
Regardless of the clinical measure used, sildenafil proved to be a much more effective ED treatment than apomorphine, said lead investigator Ian Eardley, M.A., M.Chir., FRCS(Urol), FEBU, Leeds General Infirmary and St. James's University Hospital in Britain.
The 20-week cross-over trial involving 118 men found that 75 percent of intercourse attempts were successful for men taking Viagra, compared to 35 percent of attempts for men taking Uprima. Viagra users also showed significant improvement in erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction.
The Global Assessment Questionnaire (GAQ) found that 95 percent of men taking Viagra experienced improved erections and 94 percent improved intercourse, compared to 52 percent and 49 percent respectively on Uprima.
These results plus the five years of prescribing experience really underscore the benefits of treating ED patients with sildenafil, said Mr Eardley.
Viagra is a prescription medication available only from doctors and should always be used in accordance with its approved labeling. Viagra is contraindicated in patients who use nitrates in any form at any time. The most common side effects of Viagra are headaches, facial flushing and indigestion.
Discovered and developed by Pfizer (NYSE: PFE - news) , Viagra is the breakthrough oral treatment for erectile dysfunction that has been found to be effective and well tolerated in over 100 completed and ongoing clinical studies. Viagra has been approved by regulatory authorities in over 119 countries around the world and is among the most widely prescribed medications, with over 120 million prescriptions written for more than 20 million men.